Stintzing S, Heinrich K, Tougeron D, Modest DP, et al. FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF(V600E)-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study. J Clin Oncol 2023 Jun 23:JCO2201420. doi: 10.1200/JCO.22.01420.
PMID: 37352476